Avid Bioservices Inc (CDMO)
7.085
+0.18
(+2.68%)
USD |
NASDAQ |
Jun 14, 16:00
7.08
0.00 (0.00%)
After-Hours: 20:00
Avid Bioservices Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| April 30, 2015 | 43.00M |
| April 30, 2014 | 27.72M |
| April 30, 2013 | 24.31M |
| April 30, 2012 | 35.69M |
| April 30, 2011 | 29.46M |
| April 30, 2010 | 24.66M |
| April 30, 2009 | 18.42M |
| April 30, 2008 | 18.28M |
| April 30, 2007 | 15.88M |
| April 30, 2006 | 12.42M |
| Date | Value |
|---|---|
| April 30, 2005 | 11.16M |
| April 30, 2004 | 9.673M |
| April 30, 2003 | 8.744M |
| April 30, 2002 | 13.51M |
| April 30, 2001 | 7.38M |
| April 30, 2000 | 8.075M |
| April 30, 1999 | 8.80M |
| April 30, 1998 | 7.60M |
| April 30, 1997 | 30.00M |
| April 30, 1996 | 1.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Catalent Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.63M |
| iBio Inc | 10.33M |
| Theriva Biologics Inc | 14.31M |